In 2018, the NIH-led Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain workshop convened scientific leaders from academia, industry, government and patient advocacy groups to discuss progress, challenges, gaps and ideas to facilitate the development of biomarkers and end points for pain. The outcomes of this workshop are outlined in this Consensus Statement, which appeared in the Nature Reviews Neurology journal, published online on June 15, 2020.

Read the Paper: Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities